Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated in neurodegenerative diseases like Parkinson's ...
A team led by University of Pittsburgh School of Public Health geneticists has shown, for the first time, that a gene "silencer" that resides in junk DNA is directly sparing people from a devastating ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...
Fingernail-sized vibrating gadgets, similar to the tiny devices that make your cellphone buzz, could help people with ...
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...